18-2578029-G-C
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_006101.3(NDC80):āc.364G>Cā(p.Val122Leu) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000327 in 1,613,926 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 12/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā ).
Frequency
Consequence
NM_006101.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
NDC80 | NM_006101.3 | c.364G>C | p.Val122Leu | missense_variant | 5/17 | ENST00000261597.9 | NP_006092.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
NDC80 | ENST00000261597.9 | c.364G>C | p.Val122Leu | missense_variant | 5/17 | 1 | NM_006101.3 | ENSP00000261597 | P1 | |
NDC80 | ENST00000576274.2 | c.82G>C | p.Val28Leu | missense_variant | 2/4 | 3 | ENSP00000476919 |
Frequencies
GnomAD3 genomes AF: 0.000276 AC: 42AN: 152158Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.000374 AC: 94AN: 251364Hom.: 0 AF XY: 0.000390 AC XY: 53AN XY: 135848
GnomAD4 exome AF: 0.000332 AC: 486AN: 1461768Hom.: 0 Cov.: 31 AF XY: 0.000322 AC XY: 234AN XY: 727190
GnomAD4 genome AF: 0.000276 AC: 42AN: 152158Hom.: 0 Cov.: 32 AF XY: 0.000215 AC XY: 16AN XY: 74340
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Oct 18, 2021 | The c.364G>C (p.V122L) alteration is located in exon 5 (coding exon 4) of the NDC80 gene. This alteration results from a G to C substitution at nucleotide position 364, causing the valine (V) at amino acid position 122 to be replaced by a leucine (L). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at